We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Joanna Owens, PhD

Joanna Owens, PhD

Contact Us


Joanna brings more than 20 years’ experience writing about a wide range of scientific topics in biosciences, pharmaceuticals and biotechnology. After a PhD in Molecular Toxicology, Joanna began a career in science publishing, as associate editor on Drug Discovery Today and later as senior editor, Nature Reviews Drug Discovery. In 2007, she joined one of the world’s largest biomedical charities, Cancer Research UK, specializing in plain language science communications for patients and the public. Joanna has been a freelance writer since 2017, covering all biomedical topics with a focus on oncology, pharmacology and drug discovery.


Latest Content
Cryopreservation: Applications and Advances content piece image
Article

Cryopreservation: Applications and Advances

In this article, we explore the challenges with cryopreservation and the emerging advances that could improve these methods.
Advances in Antibody Screening content piece image
Article

Advances in Antibody Screening

In this article, we explore recent developments in antibody screening that can quickly identify and prioritize antibodies for further development.
Exploring the Human Chronobiome and Precision Medicine Approaches content piece image
Article

Exploring the Human Chronobiome and Precision Medicine Approaches

We recently spoke with Carsten Skarke, MD, the McNeil Fellow in Translational Medicine and Therapeutics at the University of Pennsylvania to learn more about his work on the human chronobiome, its relevance in terms of timing the delivery of therapeutics and developing precision medicines.
New Frontiers in Pharmacokinetics content piece image
Article

New Frontiers in Pharmacokinetics

In this article, we look at two factors that may impact the pharmacokinetics of drugs; our gender, and the microbes we share our body with.
The Global Push for a COVID-19 Vaccine content piece image
Article

The Global Push for a COVID-19 Vaccine

Worldwide, researchers are racing to develop a vaccine against SARS-CoV-2, the virus that causes COVID-19. Many different parties within the scientific community are working to develop a vaccine – from scientists who have dedicated their careers to the study of coronaviruses, to specialists in vaccine design from both academia and industry, to those in other disciplines who have redirected their efforts to combat this global health threat. In this article, we meet some of the teams who are at the forefront of this endeavor.
Six Steps Towards Understanding the Microbiome and Cancer content piece image
Listicle

Six Steps Towards Understanding the Microbiome and Cancer

In cancer, rapidly emerging evidence suggests that the microbiome influences disease progression in a myriad of direct and indirect ways. In this listicle, we look at recent research developments directed towards exploring the emerging “oncomicrobiome”.
Diverse Applications of High-Content and High-Throughput Screening content piece image
Article

Diverse Applications of High-Content and High-Throughput Screening

In this article, we use COVID-19 and cancer to illustrate the range of screening tools at our fingertips today.
Targeting the Tumor Microenvironment content piece image
Article

Targeting the Tumor Microenvironment

In this article, we learn why it’s not just the tumor itself that needs to be targeted and hear about research that aims to exploit the tumor microenvironment.
Advances in High-Throughput Screening content piece image
Article

Advances in High-Throughput Screening

Ever since the advent of the multi-well plate, researchers have been pioneering new ways to miniaturize assays for high-throughput screening (HTS). Here, we share two examples that illustrate the power of modern HTS in drug discovery.
Advances in Cancer Drug Discovery content piece image
Article

Advances in Cancer Drug Discovery

From optimizing immunotherapy to second-guessing cancer’s next evolutionary step – there has never been a more innovative era in cancer drug discovery.
Advertisement